GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?

GoodRx Holdings, Inc. (NASDAQ: GDRX ) isn’t a biotech story, as it doesn’t invent new drugs or push them through the FDA. It’s the rails of the U.S. pharmacy system, or the infrastructure that makes the difference betweenI’m passionate about finance and investing, focusing on business analysis, fundamental analysis, valuation, and long-term growth, especially in sectors like AI, fintech, finance and tech. I study finance and economy and have hands-on experience in equity research, financial modeling, and cr ...